47
In band
Moving averages
SMA 50$264.90-1.31%
SMA 200$242.92+7.62%
EMA 20$262.84-0.53%
Company profile
Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government.
SectorHealthcare
IndustryDrug Manufacturers - General
Market cap$630.04B
P/E ratio30.29
EPS$8.63
Beta0.206
Dividend yield2.04%
52-week high$281.07
52-week low$180.57
Insider transactions
Latest news
Earnings call transcript
Q2 2026Options chain
Similar stocks in Drug Manufacturers - General
RSI alerts for JNJ
Get an email the moment Johnson & Johnson crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 11 October 2026 at 9:25 PM EDT